Document Type : Original Article


1 Research Scholar, Research and Development Centre, Bharathiar University, Coimbatore, Tamil Nadu, India

2 Head, Department of Biotechnology, Sri Krishna College and Arts and Science, Coimbatore, Tamil Nadu, India

3 Deputy Chief Scientist, RndBio, Coimbatore, Tamil Nadu, India


Objective: Intravascular catheter-associated infection has been increasing hospitalization in post-surgery patients mainly due to microbial colonization of the catheter surface and formation of a superficial biofilm layer. The present study is aimed in developing an effective antibacterial device which can prevent colonization of organisms by modification of catheter. Methods: In the present study, the antibacterial activities of intravascular catheters are impregnated with third generation broad spectrum antibiotic cefixime under in vitro conditions. To enhance sustained drug release from the catheter surface, a carrier polyvinyl alcohol was added as a second layer. Biofilm forming abilities for the test cultures were initially determined using a standard Exit-site challenge test viz., Borosilicate tube assay and Microtitre plate assay .These test were performed to evaluate the biofilm production using biofilm index. Results: Qualitative and quantitative antibacterial activity tests were performed in modified catheters. It was observed that modified catheters could potentiality prevent the growth of test organisms. During the in vitro conditions it was observed that the growth and survival all the four high biofilm producers viz., Staphylococcus epidermidis, Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and the moderate biofilm producer, Proteus mirabilis were prevented when exposed to drug-carrier coated catheters. These in vitro results suggest that the antibacterial drug-carrier coated catheters can potentially be used to combat catheter colonization and catheter-associated infections.


Bayston R, Fisher LE and Weber K (2009). An antimicrobial modified silicone peritoneal catheter with activity against both Gram positive and Gram negative bacteria. Biomaterials. 30(18): pp. 3167-3173.
Boccaccini AR, Stamboulis AG, Rashid A, Roether JA (2003). Composite surgical sutures with bioactive glass coating. J Biomed Mater Res B Appl Biomater. 67: pp.618ñ626.
Cho YW, Park JH, Kim SH, Cho YH, Choi JM, Shin HJ, Bae YH, Chung H, Jeong SY, Kwon IC (2003). Gentamicinreleasing urethral catheter for short-term catheterization. J Biomater Sci Polym Ed. 14: pp. 963ñ972.
Christensen GD, Simpson WA, Younger JA, Baddour LM, Barrett FF and Melton DM (1985). Adherence of cogulase negative Staphylococi to plastic tissue cultures: a quantitative model for the adherence of staphylococci to
medical devices. Journal of Clinical Microbiology. 22:pp.996ñ1006.
Donlan MR (2011). Biofilm Elimination on Intravascular Catheters: Important considerations for the infectious disease Practitioner. Healthcare epidemiology. 52(8):pp.1038- 1045.
Donlan RM (2001). Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis. 33: pp. 1387ñ92.
El-Rehewy MK, El-Feky MA, Hassan MA, Abolella HA, Abolyosr A, El-Baky RMA, Gad GF (2009). In vitro Efficacy of Ureteral Catheters Impregnated with
Ciprofloxacin, N-acetylcysteine and their Combinations on Microbial Adherence, Clinical Medicine: Urology. 3: pp.1ñ8.2724
Gollwitzer H, Ibrahim K, Meyer H, Mittelmeier WR, Busch R, Stemberger A. (2003) Antibacterial poly (D, L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. Journal of Antimicrobial
Chemotherapy. 51: pp. 585ñ591.
Liedberg H, Lundeberg T (1990). Silver alloy-coated catheters reduce catheter-associated bacteriuria. British Journal of Urology. 65: pp. 379ñ381.
Mathur T, Singhal S, Khan S, Upadhyay DJ, Fatma T, Rattan A, (2006). Detection of biofilm formation among the clinical isolates of Staphylococci: an evaluation of three different screening methods, Indian Journal of
Medical Microbiology. 24(1): pp. 25-9.
Matl FD, Obermeier A, Repmann S, Friess W, Stemberger A and Kuehn KD (2008). New anti-infective coatings of medical implants, Antimicrobial Agents and Chemotherapy. 52: pp.1957-1963.
Memon IA, Billoo AG, Memon HI (1997). Cefixime an oral option for the treatment of multidrug-resistant enteric fever in children. South Med J. 90(12): pp.1204-7.
O'Toole GA, Pratt LA, Watnick PI, Newman DK, Weaver VB, Kolter R (1999). Genetic approaches to study of biofilms. Methods Enzymol. 310: pp. 91ñ109.
Petri WA (2006). Penicillins, Cephalosporins and other ‚- Lactam antibiotics. In: Goodman and Gilmanís. The Pharmacological Basis of Therapeutics. 11th eds. U.S.A: McGraw- Hill Co. Incorp.
Rafal'skii VV, Divgan EV, Derevitskiĭ AV (2011). Cefixim: clinical pharmacology and role in therapy of urogenital infections. Urologiia. 2: pp. 63-6.
Reid G. Sharma S. Advikolanu K. Tieszer C. Martin RA, Bruce AW (1994). Effects of ciprofloxacin, norfloxacin, and ofloxacin on in vitro adhesion and survival of Pseudomonas aeruginosa AK1 on urinary catheters, Antimicrobial Agents and Chemotherapy. 38: pp.1490-1495.
Rodrigues L, Banat IM, Teixeira J, Oliveira R (2007). Strategies for the prevention of microbial biofilm formation on silicone rubber voice prostheses. J Biomed Mater Res B Appl Biomater. 81: pp. 358ñ370.
Roether JA, Boccaccini AR, Hench LL, Maquet V, Gautier S, Jerjme R (2002). Development and in vitro characterisation of novel bioresorbable and bioactive
composite materials based on polylactide foams and bioglass for tissue engineering applications. Biomaterials. 23: pp. 3871ñ3878.
Sabbuba N, Hughes G, Stickler DJ (2002). The migration of proteus mirabilis and other urinary tract pathogens over Foley catheters. BJU Int. 89: pp. 55ñ60.
Safdar N, Maki DG (2004). The pathogenesis of catheterrelated blood- stream infection with noncuffed shortterm central venous catheters. Intensive Care Med. 30(1):pp. 62-67.
Shaw GL, Choong SK, Fry C (2005). Encrustation of biomaterials in the urinary tract. Urol Res. 33: pp. 17ñ22. 
Srinivasan A, Karchmer T, Richards A, Song X, Perl TM (2006). A prospective trial of a novel, silicone-based, silver-coated Foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp
Epidemiol. 27: pp. 38ñ43.
Stamboulis AG, Boccaccini AR, Hench LL (2002). Novel biodegradable polymer/bioactive glass composites for tissue engineering applications. Adv Eng Mater. 4:pp.105ñ109.
Treter J, Macedo AJ (2011). Catheters: a suitable surface for biofilm formation Science against microbial pathogens: communicating current research and
technological advances. A. MÈndez-Vilas (Ed.). Formatex.pp. 835- 839.
Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel
RP, Edmond MB (2004). Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin infectdis: 39(3): pp. 309- 317.
Wu P, Grainger DW (2006). Drug/device combinations for local drug therapies and infection prophylaxis. Biomaterials. 27: pp. 2450ñ2467.